Immunomedics, Inc. (IMMU)


Stock Price Forecast

Oct. 22, 2020


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Immunomedics, Inc. chart...

About the Company

Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.

Sector

Health Technology

Industry

Biotechnology

Employees

366

Exchange

NASDAQ

Website

http://www.immunomedics.com

$20M

Total Revenue

366

Employees

$18B

Market Capitalization

-51.08

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $IMMU News

Buy Gilead on Immunomedics Deal? Let's Look at the Charts

3y ago, source: TheStreet.com

Gilead Sciences is up slightly on Monday after announcing an agreement to buy Immunomedics. Here's how the stock is setting up on the charts now. The deal is worth $21 billion and values ...

Seagen Stock Leaps On Report Of $40 Billion Takeover By Merck & Co.

1y ago, source: TheStreet.com

with Gilead Sciences paying $21 billion for cancer treatments specialists Immunomedics Inc. IMMU in 2020. Scott Gottlieb, the former Commissioner of the U.S. Food & Drug Administration ...

Robert Azelby's Net Worth

1mon ago, source: Benzinga.com

This is based on reported shares across multiple companies, which include Cascadian Therapeutics, Inc., IMMUNOMEDICS INC, ALDER BIOPHARMACEUTICALS INC, Eliem Therapeutics, Inc., Clovis Oncology ...

Boom Or Kaboom? M&A Is Hitting Records – But Some Activists ‘Just Say No’

2y ago, source: Forbes

Avoro is a highly credible activist investor, having pushed for the October 2020 acquisition of Immunomedics ... is the proposed acquisition by Zendesk Inc. ZEN of Momentive Global Inc., the ...

Welcome to Inc.'s Directory of B2B Excellence

2mon ago, source: Inc

They all made it through Inc.'s proprietary vetting process, based in part on testimonials from other clients. As any entrepreneur knows, the right partnership can make all the difference.

Ocuphire Pharma, Inc. (OCUP)

2d ago, source: Yahoo Finance

FARMINGTON HILLS, Mich., April 22, 2024 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage biopharmaceutical company focused ...

Acute Myeloid Leukemia Market Size is Expected to Grow by 2032 | DelveInsight

9d ago, source:

As per DelveInsight analysis, the Acute Myeloid Leukemia market is anticipated to witness growth at a considerable CAGR.

Gilead Sciences Inc GILD

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Etsy Inc.

2d ago, source: Wall Street Journal

1 Day ETSY -0.46% DJIA 0.67% S&P 500 0.87% Retail/Wholesale 0.37% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the ...

MPW Medical Properties Trust, Inc.

5d ago, source: Seeking Alpha

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama ...

About Inc.com | Everything You Need to Know to Grow and Start Your Business

12y ago, source: Inc

Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...

Nike Inc. Cl B

2y ago, source: MarketWatch

Under Armour Inc. Cl C 1.39% $2.9B Under Armour Inc. Cl A 0.74% $2.9B ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...